← SkinHealth Systems Inc.
| Annual Trend | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Net loss | ($1.6m) | ($1.1m) | ($375.1m) | $44.4m | ($100.1m) | ($29.1m) | ($9.5m) | — | |
| Net Income | — | — | — | $44.2m |
($100.1m)
-326.38%
|
($29.1m)
+70.94%
|
($9.5m)
+67.29%
|
($28.4m)
-198.71%
|
|
| Amortization of intangible assets | $12.5m | $11.8m | $13.3m | $14.9m | $20.9m | $19.5m | $17.0m | — | |
| Depreciation of property and equipment | $1.4m | $2.6m | $4.5m | $7.2m | $11.3m | $9.9m | $3.8m | $24.4m | |
| Amortization of other assets | $63k | $132k | $147k | $857k | $2.4m | $4.2m | $4.5m | — | |
| Amortization of debt issuance costs | — | — | $4.1m | $4.2m | $4.2m | $3.3m | $3.6m | — | |
| Amortization Cash Flow | — | — | — | $15.7m | $23.3m | $23.7m | $21.5m | — | |
| Amortization Of Intangibles | — | — | — | $15.7m | $23.3m | $23.7m | $21.5m | $22.0m | |
| Depreciation Amortization Depletion | — | — | — | $22.9m | $34.7m | $33.7m | $25.3m | $24.4m | |
| Deferred income taxes | — | — | — | ($1.8m) | ($1.1m) | ($3.7m) | $2.2m | $951k | |
| Deferred Tax | — | — | — | ($1.8m) | ($1.1m) | ($3.7m) | $2.2m | $951k | |
| Share-based compensation | $103k | $363k | $12.4m | $28.5m | $22.5m | $26.7m | $14.8m | $11.0m | |
| Asset Impairment Charge | — | — | — | $5.1m | $37.8m | $28.0m | $7.2m | $5.5m | |
| Change In Working Capital | — | — | — | ($145.3m) | $23.4m | ($27.4m) | $10.4m | ($2.5m) | |
| Accounts receivable | ($11.0m) | $3.7m | ($31.0m) | ($32.0m) | $16.5m | $20.8m | $5.2m | $6.3m | |
| Change In Receivables | — | — | — | ($32.0m) | $16.5m | $20.8m | $5.2m | $6.3m | |
| Changes In Account Receivables | — | — | — | ($32.0m) | $16.5m | $20.8m | $5.2m | $6.3m | |
| Inventory write-down | — | — | $1.1m | $5.1m | $18.3m | $28.0m | $7.2m | — | |
| Syndeo inventory write-down | — | — | $0 | $0 | $19.6m | $0 | $0 | — | |
| Inventories | ($4.8m) | ($3.2m) | ($9.4m) | ($82.1m) | ($22.6m) | ($10.5m) | $15.8m | $7.2m | |
| Change In Inventory | — | — | — | ($84.4m) | ($22.6m) | ($10.5m) | $15.8m | $7.2m | |
| Accounts payable, accrued expenses, and income tax payable | — | — | — | ($3.0m) | $44.0m | ($43.8m) | ($7.2m) | ($73.8m) | |
| Change In Payables And Accrued Expense | — | — | — | ($3.0m) | $44.0m | ($43.8m) | ($7.2m) | ($73.8m) | |
| Change In Accrued Expense | — | — | $24.8m | ($3.4m) | $26.9m | — | — | — | |
| Prepaid expenses, other current assets, and income tax receivable | ($1.1m) | $489k | ($5.4m) | ($16.4m) | ($3.3m) | $15.5m | $3.4m | — | |
| Change In Other Current Assets | — | — | ($6.1m) | ($8.0m) | — | — | — | — | |
| Change In Other Current Liabilities | — | — | ($1.4m) | ($4.0m) | — | — | — | — | |
| Net cash provided by operating activities | $1.7m |
($12.4m)
-819.68%
|
($28.4m)
-128.06%
|
($106.6m)
-275.87%
|
$21.8m
+120.40%
|
$16.1m
-25.82%
|
$37.5m
+132.34%
|
$22.0m
-41.42%
|
|
| Cash paid for property and equipment | ($8.8m) | ($3.5m) | ($11.2m) | ($10.8m) | ($3.8m) | ($756k) | ($303k) | — | |
| Capital Expenditure | — | — | ($15.6m) | ($17.4m) | ($13.0m) | ($6.8m) | ($5.2m) | ($5.3m) | |
| Cash paid for asset acquisitions | — | $0 | $0 | ($1.5m) | ($18.5m) | $0 | $0 | — | |
| Payment of contingent considerations related to acquisitions | $0 | ($901k) | $0 | ($4.3m) | ($1.8m) | $0 | $0 | — | |
| Net Other Investing Changes | — | — | $781k | ($1.5m) | ($18.5m) | — | — | — | |
| Net cash used for investing activities | ($12.5m) | ($3.8m) | ($37.7m) | ($18.9m) | ($31.5m) | ($6.8m) | ($5.2m) | — | |
| Issuance Of Debt | — | — | — | $0 | $0 | $0 | $237.6m | ($701k) | |
| Long Term Debt Issuance | — | — | — | $0 | $0 | $0 | $237.6m | ($701k) | |
| Long Term Debt Payments | — | — | — | $0 | $0 | ($156.1m) | ($411.0m) | ($20.2m) | |
| Net Issuance Payments Of Debt | — | — | — | $0 | $0 | ($156.1m) | ($173.4m) | ($20.9m) | |
| Net Long Term Debt Issuance | — | — | — | $0 | $0 | ($156.1m) | ($173.4m) | ($20.9m) | |
| Net Short Term Debt Issuance | — | — | $0 | $0 | $0 | — | — | — | |
| Repayment Of Debt | — | — | — | $0 | $0 | ($156.1m) | ($411.0m) | ($20.2m) | |
| Short Term Debt Issuance | — | — | $5.0m | $0 | $0 | — | — | — | |
| Short Term Debt Payments | — | — | ($5.0m) | $0 | $0 | — | — | — | |
| Repurchase of common stock | $0 | ($154k) | $0 | ($160.0m) | ($30.2m) | $0 | $0 | — | |
| Class A Common Stock issued for asset acquisition | — | — | $0 | $500k | $1.3m | $0 | $0 | — | |
| Common Stock Payments | — | — | — | ($160.0m) | ($32.4m) | $0 | $0 | $0 | |
| Net Common Stock Issuance | — | — | — | ($160.0m) | ($32.4m) | $0 | $0 | $0 | |
| Repurchase Of Capital Stock | — | — | — | ($160.0m) | ($32.4m) | $0 | $0 | $0 | |
| Net Other Financing Charges | — | — | — | ($45.2m) | ($5.1m) | ($2.3m) | ($1.6m) | ($1.6m) | |
| Net cash used for financing activities | $14.6m |
$18.3m
+25.35%
|
$959.0m
+5148.37%
|
($205.2m)
-121.40%
|
($37.4m)
+81.75%
|
($158.3m)
-322.83%
|
($174.9m)
-10.47%
|
— | |
| Cash, cash equivalents, and restricted cash beginning of period | $7.3m | $9.5m | $901.9m | $568.2m | $523.0m | $370.1m | $232.7m | — | |
| Beginning Cash Position | — | — | — | $901.9m | $568.2m | $523.0m | $370.1m | $212.0m | |
| Net change in cash, cash equivalents, and restricted cash | $3.8m | $2.0m | $892.9m | ($330.7m) | ($47.2m) | ($149.0m) | ($142.6m) | — | |
| Effect Of Exchange Rate Changes | — | — | — | ($3.0m) | $2.0m | ($4.0m) | $5.2m | ($121k) | |
| Additional Supplementary Disclosures | |||||||||
| Additional Supplementary Disclosures | |||||||||
| Provision for estimated credit losses | $659k | $1.4m | $854k | $1.6m | $5.2m | $5.1m | $2.1m | — | |
| Change in fair value of warrant liabilities | $0 | $0 | $277.3m | ($78.3m) | ($11.9m) | ($3.1m) | ($487k) | — | |
| Gain on exchange and repurchases of convertible senior notes, net | — | — | — | $0 | $0 | ($33.4m) | ($18.1m) | — | |
| Other, net | — | — | $0 | ($4.3m) | $0 | ($302k) | $0 | — | |
| Cash paid for intangible assets | ($1.6m) | ($316k) | ($4.4m) | ($6.5m) | ($9.2m) | ($6.0m) | ($4.9m) | — | |
| Repurchase of 2026 Notes in connection with exchange | — | — | — | — | $0 | $0 | ($392.6m) | — | |
| Issuance of 2028 Notes in connection with exchange, net | $0 | $0 | $750.0m | $0 | $0 | $0 | $237.6m | — | |
| Repurchase of 2026 Notes | — | — | — | $0 | $0 | ($156.1m) | ($18.4m) | — | |
| Payment of tax withholdings on vested stock awards | — | $0 | $0 | ($927k) | ($3.2m) | ($2.0m) | ($1.6m) | — | |
| Payment of accelerated share repurchases | — | — | $0 | $0 | ($2.2m) | $0 | $0 | — | |
| Effect of foreign currency translation on cash | ($94k) | $159k | ($543k) | ($3.0m) | $2.0m | ($4.0m) | $5.2m | — | |
| Cash paid for interest | $15.7m | $13.5m | $10.2m | $9.8m | $9.4m | $8.0m | $14.4m | — | |
| Cash Flow From Continuing Financing Activities | — | — | — | ($205.2m) | ($37.4m) | ($158.3m) | ($174.9m) | ($22.4m) | |
| Cash Flow From Continuing Investing Activities | — | — | — | ($18.9m) | ($31.5m) | ($6.8m) | ($5.2m) | ($5.3m) | |
| Change In Account Payable | — | — | $10.5m | $1.6m | $15.8m | — | — | ($73.8m) | |
| Change In Cash Supplemental As Reported | — | — | — | ($330.7m) | ($47.2m) | ($149.0m) | ($142.6m) | — | |
| Change In Income Tax Payable | — | — | ($594k) | $198k | $1.3m | — | — | — | |
| Change In Other Working Capital | — | — | — | ($12.1m) | ($7.6m) | ($9.4m) | ($6.8m) | ($6.8m) | |
| Change In Payable | — | — | $9.9m | $1.8m | $17.1m | — | — | ($73.8m) | |
| Change In Prepaid Assets | — | — | — | ($13.8m) | ($7.0m) | $15.5m | $3.4m | ($14.8m) | |
| Change In Tax Payable | — | — | ($594k) | $198k | $1.3m | — | — | — | |
| Changes In Cash | — | — | — | ($330.7m) | ($47.2m) | ($149.0m) | ($142.6m) | ($5.8m) | |
| End Cash Position | — | — | — | $568.2m | $523.0m | $370.1m | $232.7m | $206.2m | |
| Financing Cash Flow | — | — | — | ($205.2m) |
($37.4m)
+81.75%
|
($158.3m)
-322.83%
|
($174.9m)
-10.47%
|
($22.4m)
+87.17%
|
|
| Free Cash Flow | — | — | — | ($124.0m) | $8.7m | $9.3m | $32.3m | $16.6m | |
| Gain Loss On Investment Securities | — | — | — | ($78.3m) | ($11.9m) | ($3.1m) | ($487k) | ($627k) | |
| Gain Loss On Sale Of PPE | — | — | $0 | $5.2m | — | — | — | — | |
| Investing Cash Flow | — | — | — | ($18.9m) | ($31.5m) | ($6.8m) | ($5.2m) | ($5.3m) | |
| Net Business Purchase And Sale | — | — | ($22.9m) | $0 | $0 | — | — | — | |
| Net Foreign Currency Exchange Gain Loss | — | — | $0 | $2.4m | — | — | — | $2.4m | |
| Net Intangibles Purchase And Sale | — | — | — | ($6.5m) | ($9.2m) | ($6.0m) | ($4.9m) | ($4.5m) | |
| Net PPE Purchase And Sale | — | — | — | ($10.8m) | ($3.8m) | ($756k) | ($303k) | ($817k) | |
| Operating Gains Losses | — | — | — | ($78.3m) | ($11.9m) | ($3.1m) | ($487k) | ($627k) | |
| Other Non Cash Items | — | — | — | $16.4m | $11.3m | ($14.1m) | ($14.6m) | — | |
| Proceeds From Stock Option Exercised | — | — | $188.4m | $0 | $0 | — | — | $0 | |
| Provisionand Write Offof Assets | — | — | — | $1.6m | $5.2m | $5.1m | $2.1m | $1.1m | |
| Purchase Of Business | — | — | ($22.9m) | $0 | $0 | — | — | — | |
| Purchase Of Intangibles | — | — | — | ($6.5m) | ($9.2m) | ($6.0m) | ($4.9m) | ($4.5m) | |
| Purchase Of PPE | — | — | $11.2m | ($10.8m) | ($3.8m) | ($756k) | ($303k) | ($5.3m) | |
| Stock Based Compensation | — | — | — | $28.5m | $22.5m | $26.7m | $14.8m | $11.0m |